background
respiratori
viral
infect
rvi
lead
caus
mortal
worldwid
compar
epidemiolog
sever
rvi
ecuador
method
respiratori
specimen
collect
within
nation
surveil
system
test
influenza
virus
respiratori
syncyti
viru
rsv
adenoviru
parainfluenza
viru
human
metapneumoviru
overal
virusspecif
posit
detect
rate
pdr
calcul
compar
time
epidem
caus
differ
virus
logist
regress
model
use
compar
age
distribut
risk
death
across
respiratori
virus
result
total
specimen
analyz
influenza
pdr
respiratori
syncyti
viru
rsv
pdr
frequent
detect
virus
influenza
epidem
typic
peak
decemberjanuari
rsv
epidem
march
season
less
evid
virus
compar
adult
children
frequent
infect
rsv
adenoviru
parainfluenza
influenza
b
elderli
less
frequent
infect
influenza
p
ageadjust
risk
death
highest
p
odd
ratio
confid
interv
ci
lowest
rsv
ci
conclus
whilst
influenza
rsv
frequent
detect
pathogen
risk
death
differ
rvi
highest
pandem
influenza
lowest
rsv
respiratori
viral
infect
rvi
usual
mild
tend
resolv
spontan
without
treatment
exac
erbat
superimpos
bacteri
pneumonia
bronchiti
otiti
media
sever
complic
requir
hospit
lifethreaten
especi
among
young
elderli
subject
underli
medic
condit
widespread
diffus
potenti
sever
complic
rvi
lead
caus
mortal
disabl
worldwid
particularli
develop
countri
among
children
five
year
age
causal
agent
rvi
includ
influenza
virus
respiratori
syncyti
viru
rsv
parainfluenza
virus
adenoviru
other
rvi
typic
present
nonspecif
symptom
like
cough
fever
rhinorrhoea
causal
virus
may
larg
differ
one
anoth
term
epidemiolog
tempor
appear
throughout
year
age
distribut
sever
addit
influenza
prevent
vaccin
treat
antivir
current
vaccin
therapeut
proven
efficaci
respiratori
virus
world
health
organ
launch
battl
respiratori
virus
brave
initi
aim
tackl
burden
diseas
rvi
global
brave
initi
identifi
prioriti
research
track
topic
area
futur
rvi
studi
stress
need
better
defin
epidemiolog
burden
diseas
specif
rvi
across
age
spectrum
set
prerequisit
implement
effect
public
health
intervent
particularli
import
lowand
middleincom
tropic
countri
rvi
place
massiv
burden
rel
fragil
healthcar
system
highest
socioeconom
impact
ecuador
tropic
countri
locat
southern
america
total
popul
million
inhabit
influenza
epidemiolog
ecuador
previous
describ
compar
analysi
rvi
caus
differ
virus
still
lack
consist
brave
research
line
present
compar
studi
epidemiolog
age
distribut
sever
acut
rvi
ecuador
ecuador
cross
equat
divid
four
region
coast
sierra
orient
mainland
island
pacif
ecuador
popul
live
coast
sierra
region
median
age
year
respiratori
viru
surveil
data
avail
analysi
two
major
chang
surveil
system
period
data
initi
week
collect
influenzalik
ill
ili
sever
acut
respiratori
infect
sari
patient
swab
four
provinc
countri
short
durat
limit
geograph
coverag
small
sampl
size
specimen
overal
data
period
use
analys
week
week
univers
surveil
scheme
implement
wherebi
ili
sari
patient
present
hospit
local
health
unit
airport
harbour
countri
swab
final
week
end
studi
period
sentinel
surveil
scheme
sari
place
includ
select
hospit
local
health
unit
whole
countri
eventbas
surveil
system
also
place
collect
inform
unusu
respiratori
event
pose
potenti
risk
public
health
defin
hospit
deceas
sari
case
match
least
one
follow
criteria
age
year
comorbid
healthcar
worker
swine
poultri
worker
recent
travel
site
transmiss
highli
pathogen
respiratori
agent
belong
sari
cluster
unusu
sari
case
left
databas
sinc
provid
specimen
exclus
alter
result
ili
case
defin
person
sudden
onset
fever
c
cough
sore
throat
absenc
altern
caus
sari
case
defin
subject
age
year
sudden
onset
fever
c
cough
sore
throat
difficulti
breath
requir
hospit
admiss
children
age
year
suspect
sever
pneumonia
requir
hospit
follow
respiratori
virus
search
influenza
pandem
b
rsv
adenoviru
parainfluenza
viru
type
sinc
human
metapneumoviru
hmpv
detect
respiratori
virus
made
use
nasal
swab
laboratori
test
conduct
nation
influenza
refer
laboratori
guayaquil
two
region
laboratori
quito
cuenca
detect
influenza
virus
perform
use
realtim
polymeras
chain
reaction
rtpcr
accord
protocol
us
center
diseas
control
prevent
viral
rna
extract
use
commerci
avail
kit
quickrna
tm
viral
zymo
research
qiaamp
viral
rna
mini
kit
qiagen
accord
instruct
provid
manufactur
specimen
whose
cross
point
amplif
curv
consid
posit
detect
respiratori
virus
influenza
made
use
direct
immunofluoresc
assay
light
diagnost
tm
respiratori
viral
screen
identif
dfa
kit
millipor
ultra
tm
dfa
respiratori
viru
screen
id
kit
diagnost
hybrid
retrospect
analys
data
collect
within
nationwid
surveil
system
respiratori
viral
infect
ecuador
differ
statist
approach
adopt
order
answer
specif
studi
question
overal
virusspecif
posit
detect
rate
pdr
defin
proport
specimen
test
posit
least
one
respect
given
respiratori
viru
patient
infect
parainfluenza
viru
type
analyz
togeth
due
limit
number
overal
virusspecif
pdr
calcul
overal
separ
surveil
scheme
patient
age
group
month
year
gender
region
coast
sierra
orient
island
consid
limit
number
sampl
averag
monthli
virusspecif
pdr
calcul
averag
year
data
use
analysi
influenza
pandem
order
compar
time
epidem
caus
respiratori
viru
except
adenoviru
hmpv
limit
number
case
multinomi
logist
regress
model
fit
compar
age
distribut
patient
infect
respiratori
virus
multinomi
logist
regress
model
gener
binari
logist
regress
problem
depend
variabl
nomin
two
valu
depend
variabl
result
diagnost
test
viru
detect
refer
patient
age
independ
variabl
model
adjust
year
type
surveil
scheme
region
gender
distribut
depend
variabl
compar
across
age
group
use
patient
age
year
young
adult
refer
group
regress
coeffici
express
rel
risk
ratio
rrr
interpret
follow
rrr
equal
influenza
b
among
patient
age
year
mean
rel
risk
test
posit
influenza
b
instead
test
neg
higher
among
young
adult
multivari
logist
regress
model
use
evalu
risk
death
among
patient
infect
respiratori
viru
use
testneg
patient
refer
odd
ratio
adjust
age
group
gender
year
type
surveil
scheme
region
analysi
use
data
inform
outcom
avail
previou
period
statist
analys
conduct
use
stata
version
stata
corp
colleg
station
tx
test
twosid
test
pvalu
consid
statist
signific
oral
inform
consent
obtain
patient
moment
swab
take
accord
applic
law
regul
clearanc
ethic
committe
requir
ecuador
retrospect
analysi
anonymis
data
collect
within
routin
influenza
surveil
scheme
total
specimen
collect
ili
sari
patient
sampl
week
univers
surveil
scheme
sari
patient
sampl
week
week
sentinel
surveil
scheme
tabl
term
age
distribut
specimen
children
age
less
year
year
respect
wherea
specimen
taken
among
patient
age
year
male
femal
provid
specimen
respect
almost
specimen
collect
sierra
coast
region
overal
pdr
studi
period
influenza
rsv
frequent
caus
rvi
parainfluenza
viru
adenoviru
hmpv
respect
detect
respiratori
specimen
tabl
frequent
detect
influenza
viru
sub
type
p
follow
b
circul
virus
vari
period
overal
pdr
influenza
pandem
strain
found
specimen
overal
pdr
rsv
account
nearli
half
posit
specimen
differ
emerg
also
region
frequent
detect
viru
rsv
coast
specimen
pandem
strain
sierra
contrast
differ
overal
virusspecif
pdr
gender
weekli
number
specimen
pdr
influenza
type
rsv
two
frequent
detect
respiratori
virus
shown
fig
appear
interfer
epidem
caus
influenza
rsv
epidem
caus
two
virus
never
peak
period
rsv
epidem
often
start
number
influenza
case
begun
declin
vice
versa
instanc
peak
rsvspecif
pdr
occur
earli
march
preced
follow
influenza
epidem
peak
januari
june
year
caus
b
influenza
viru
respect
averag
monthli
pdr
differ
respiratori
virus
fig
distinct
season
rsv
whose
averag
monthli
pdr
peak
march
trough
septemberoctob
month
period
year
intens
influenza
activ
embrac
decemb
pdr
januari
pdr
milder
pdr
yet
longer
peak
activ
juneaugust
peak
influenza
activ
decemb
januari
mainli
driven
p
viru
subtyp
peak
activ
juneaugust
caus
influenza
p
b
fig
weak
evid
intraannu
variat
proport
respiratori
specimen
test
posit
parainfluenza
virus
pdr
rang
novemb
march
fig
overal
pdr
rang
within
narrow
interv
age
group
except
elderli
year
tabl
virusspecif
pdr
depend
age
respiratori
virus
multinomi
logist
regress
young
children
year
significantli
like
test
posit
rsv
adenoviru
parainfluenza
hmpv
less
like
test
posit
influenza
young
adult
year
tabl
instead
older
children
year
like
detect
influenza
b
addit
rsv
adenoviru
parainfluenza
young
adult
signific
differ
young
year
older
adult
elderli
less
like
test
posit
p
influenza
like
detect
adenoviru
young
adult
inform
final
outcom
respiratori
infect
avail
patient
overal
cfr
vari
causal
agent
rsv
pandem
strain
age
group
among
children
age
year
among
elderli
differ
gender
tabl
multivari
logist
regress
odd
ratio
die
significantli
increas
among
patient
test
posit
p
ci
p
significantli
decreas
test
posit
rsv
ci
p
compar
testneg
patient
compar
young
adult
risk
die
significantli
reduc
children
age
lowest
age
year
ci
p
significantli
increas
among
elderli
ci
p
conduct
retrospect
compar
analysi
syndrom
surveil
data
ecuador
use
differ
methodolog
approach
compar
epidemiolog
age
distribut
cfr
rvi
caus
differ
virus
type
subtyp
overal
pdr
influenza
rsv
account
testposit
specimen
compar
overal
virusspecif
pdr
studi
made
problemat
variabl
factor
like
demograph
structur
countri
surveil
scheme
clinic
featur
patient
sampl
sampl
techniqu
use
laboratori
procedur
assay
may
vari
term
number
respiratori
pathogen
detect
larg
viral
aetiolog
could
establish
smaller
number
patient
compar
previou
studi
might
explain
failur
detect
common
caus
rvi
like
rhinoviru
coronaviru
other
viral
interfer
epidem
influenza
rsv
observ
previous
phenomenon
seem
affect
respiratori
virus
well
like
rhinoviru
coronaviru
adenoviru
other
although
possibl
verifi
avail
data
due
limit
number
viral
interfer
associ
prolong
shed
primari
viru
infect
ferret
influenza
model
hypothes
mechan
includ
product
interferon
cytokin
infect
cell
evid
yet
distinct
season
influenza
two
main
period
activ
decemberjanuari
juneaugust
consist
previou
report
rsv
march
less
evid
pattern
parainfluenza
ecuador
geograph
climat
divers
countri
meteorolog
paramet
like
humid
temperatur
rainfal
known
affect
viru
surviv
transmiss
viral
interfer
divers
associ
climat
paramet
factor
may
contribut
shape
season
cycl
rvi
ecuador
although
rel
import
difficult
establish
divers
age
distribut
subject
infect
differ
respiratori
virus
explain
variabl
virus
term
factor
codetermin
transmiss
dynam
among
human
reproduct
number
r
rate
mutat
accumul
durat
immun
presenc
crossprotect
rsv
two
major
antigen
group
b
antigen
variabl
may
also
occur
within
group
reproduct
number
high
immun
wane
time
featur
rsv
highest
incid
among
young
children
caus
repeat
infect
throughout
life
repres
health
threat
elderli
well
rsv
infect
also
induc
crossprotect
human
metapneumoviru
parainfluenza
viru
affect
epidemiolog
dynam
pathogen
influenza
virus
evolv
via
antigen
drift
type
viru
antigen
shift
novel
variant
introduc
constantli
commun
subtyp
shown
acceler
mutat
accumul
rate
recent
year
may
explain
higher
incid
elderli
compar
sub
type
relationship
one
age
risk
death
jshape
infant
like
die
older
children
cfr
highest
among
elderli
high
incid
among
infant
greater
sever
among
elderli
explain
popul
subgroup
suffer
largest
rvi
burden
diseas
adjust
age
patient
infect
p
higher
risk
death
compar
testneg
patient
consist
recent
literatur
report
contrast
common
belief
clinic
sever
influenza
viru
subtyp
contrast
rsv
patient
significantli
reduc
risk
death
compar
testneg
patient
given
high
raw
cfr
testneg
patient
possibl
explan
latter
could
actual
infect
untest
virus
eg
coronavirus
bocavirus
respiratori
enterovirus
bacteria
eg
mycoplasma
pneumonia
legionella
pneumophila
chlamydophila
pneumonia
microorgan
may
caus
sever
diseas
ie
higher
cfr
rsv
main
strength
paper
avail
larg
sampl
subject
age
test
multipl
respiratori
virus
within
surveil
system
cover
entir
countri
studi
limit
well
surveil
system
underw
major
transit
period
cover
studi
patient
differ
syndrom
sampl
differ
subperiod
although
analys
stratifi
adjust
account
chang
residu
confound
rule
inform
avail
patient
vaccin
statu
underli
condit
use
antivir
antibiot
influenza
virus
search
rtpcr
throughout
studi
period
identif
respiratori
virus
perform
use
direct
immunofluoresc
less
sensit
techniqu
therefor
pdr
virus
influenza
may
underestim
conclus
find
show
epidemiolog
includ
tempor
occurr
epidem
age
distribut
sever
respiratori
infect
ecuador
vari
greatli
across
virus
influenza
frequent
caus
rvi
p
subtyp
associ
highest
cfr
howev
much
burden
diseas
respiratori
infect
caus
pathogen
influenza
virus
especi
rsv
repres
public
health
prioriti
need
address
adequ
alloc
resourc
coordin
research
effort
fund
sourc
none
declar
requir
